The FDA has approved the implant for a second patient and signed off on proposed fixes to the device, the report said.
The news comes months after Noland Arbaugh, 29, became the first patient to receive the implant. Mr. Arbaugh lost all movement and sensation in his arms and legs after a diving accident but is now using the implant to operate a computer.
Earlier in May Neuralink fixed a problem with the chip’s connective threads retracting from Mr. Arbaugh, which hindered the implant’s speed and efficacy. In wake of the issue, the company plans to make the implant more sensitive to solve the problem and increase the implant’s performance even further.
Neuralink is also hoping to implant the device in a third patient in the coming months, ABC News reported May 17.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
